Twelve of 32 patients showed declines in serum PSA post-vaccination; patients with greater PSA-specific T-cell responses showed a trend toward enhanced survival.
← all excerpts
Vaccines against human carcinomas: strategies to improve antitumor immune responses.
1
—
—